Tirzepatide works on two hormone pathways at once — GLP-1 and GIP — which is why in head-to-head trials it often produces more weight loss than semaglutide. This guide explains how tirzepatide works, how it is dosed, and how it compares to semaglutide before you choose a provider.
What is tirzepatide?
Tirzepatide is sometimes described as a dual agonist. While semaglutide acts mainly on the GLP-1 receptor, tirzepatide is designed to act on two receptor pathways — GLP-1 and GIP (glucose-dependent insulinotropic polypeptide). Both are hormones involved in regulating blood sugar and appetite.
How does tirzepatide work?
At a general level, tirzepatide is understood to support effects similar to other GLP-1 treatments, through two pathways rather than one:
- Supporting signals related to fullness and appetite
- Supporting blood sugar regulation after meals
- Influencing how quickly the stomach empties
Because it engages an additional pathway, tirzepatide is often discussed as a distinct option. Whether it is suitable for you is a medical decision made by a licensed clinician based on your health history.
How is tirzepatide usually taken?
Like other GLP-1 options, tirzepatide is typically offered through a provider that includes a medical consultation, eligibility screening, and follow-up support. Availability can be more limited than semaglutide, and pricing is often higher, so comparing providers is especially useful here.
Tirzepatide vs semaglutide
The two are the most commonly compared GLP-1 options. They differ in mechanism, availability, and cost. For a clear breakdown, see our semaglutide vs tirzepatide comparison.
Choosing a provider
The provider you choose shapes access, pricing, and support. Review and compare leading programs in our guide to the best GLP-1 providers.
This article is for general informational purposes only and is not medical advice. Availability, suitability, and safety depend on your individual health profile. Always consult a licensed healthcare professional before starting any treatment.